The peptide complex contains fragments associated with the following neurotrophic factors: BDNF (brain-derived neurotrophic factor) supports neuronal survival, synaptic regulation, learning, and memory formation NGF (nerve growth factor) promotes survival of sensory neurons and supports acetylcholine signaling GDNF (glial cell line-derived neurotrophic factor) aids axonal regeneration and helps prevent neuronal apoptosis (programmed cell death) CNTF (ciliary neurotrophic factor) plays a role in protecting motor neurons from degeneration P21 a neuropeptide fragment associated with enhanced neurogenesis and brain tissue adaptability Enkephalins endogenous opioid peptides involved in stress and pain regulation Orexin influences arousal, sleep-wake cycles, appetite, and cognitive motivation A brief history of Cerebrolysin Cerebrolysin was first developed in 1949 by Austrian professor Gerhart Harrer and received regulatory approval in Austria in 1954
Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients
Scarpa, S., S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production
Brain infarct volume was quantified at 21 days post-MCAO
Among cardiac arrhythmias, atrial fibrillation (AF) and ventricular arrhythmias are the most studied ones
